XML 24 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income $ 233,856 $ 111,032 $ 7,123
Adjustments to reconcile net income to net cash provided by operating activities:      
Deferred income taxes (115,812) 63,808 63,376
Depreciation and amortization 122,266 49,394 51,834
Impairment of goodwill 0 0 87,039
Stock-based compensation (net of amounts capitalized) 15,958 13,708 8,603
Excess tax benefit from stock-based compensation 0 0 (806)
Gain from contract liability write-off (14,189) 0 0
Provision for doubtful accounts (277) 703 252
Provision for obsolete inventory 361 1,053 723
Amortization of premiums on marketable securities 124 888 2,030
Non-cash foreign currency losses, net (163) 166 196
Changes in operating assets and liabilities:      
Accounts receivable (10,343) (6,037) (1,843)
Inventory (1,946) 9,029 (169)
Prepaid expenses and other current assets 2,875 (16,613) (3,788)
Other assets 2,823 (2,128) (1,253)
Accounts payable 896 3,209 3,110
Accrued expenses and other current liabilities 8,166 (6,416) (7,815)
Deferred revenue 15,129 4,115 9,038
Accrued satellite and network operation expense, net of current portion 0 (1,045) (869)
Other long-term liabilities (103) 333 698
Net cash provided by operating activities 259,621 225,199 217,479
Cash flows from investing activities:      
Capital expenditures (400,107) (405,687) (494,810)
Purchases of marketable securities (7,013) (19,865) (204,672)
Sales and maturities of marketable securities 34,440 183,192 260,108
Net cash used in investing activities (372,680) (242,360) (439,374)
Cash flows from financing activities:      
Borrowings under the Credit Facility 22,207 251,498 230,421
Payment of deferred financing fees (3,852) (11,806) (14,984)
Proceeds from exercise of stock options 4,235 549 2,154
Tax payment upon settlement of stock awards (1,865) (627) (886)
Excess tax benefits from stock-based compensation 0 0 806
Net cash provided by financing activities 16,866 224,178 202,075
Effect of exchange rate changes on cash and cash equivalents 144 512 (755)
Net increase (decrease) in cash and cash equivalents (96,049) 207,529 (20,575)
Cash, cash equivalents, and restricted cash, beginning of period 484,306 276,777 297,352
Cash, cash equivalents, and restricted cash, end of period 388,257 484,306 276,777
Supplemental cash flow information:      
Interest paid 85,261 22,910 18,878
Income taxes paid, net 1,660 1,391 3,429
Supplemental disclosure of non-cash investing activities:      
Property and equipment received but not paid for yet 90,748 2,753 26,770
Interest capitalized but not paid 15,021 14,136 12,232
Capitalized amortization of deferred financing costs 27,304 28,688 18,372
Capitalized paid-in-kind interest 0 52,873 43,073
Capitalized stock-based compensation 2,736 2,265 1,046
Series A Preferred Stock      
Cash flows from financing activities:      
Payment of preferred stock dividends (1,750) (7,000) (7,000)
Series B Preferred Stock      
Cash flows from financing activities:      
Payment of preferred stock dividends $ (2,109) $ (8,436) $ (8,436)